Predicting cardiovascular risk: so what do we do now?
Lloyd-Jones
Donald M
DM
Tian
Lu
L
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D000367:Age Factors; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D002097:C-Reactive Protein / Q000032:analysis*; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000097:blood* / Q000453:epidemiology*; D003920:Diabetes Mellitus / Q000453:epidemiology; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D010741:Phospholipases A / Q000097:blood; D012372:ROC Curve; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking / Q000453:epidemiology; D018180:Thrombomodulin / Q000097:blood; D014481:United States / Q000453:epidemiology; D025101:Vitamin B 6 / Q000097:blood
D000959:Antihypertensive Agents; D015415:Biomarkers; D015850:Interleukin-6; D018180:Thrombomodulin; D025101:Vitamin B 6; D002097:C-Reactive Protein; D002784:Cholesterol; D010741:Phospholipases A; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase